Cell Reports (Mar 2017)

Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer

  • Koen M.A. Dreijerink,
  • Anna C. Groner,
  • Erica S.M. Vos,
  • Alba Font-Tello,
  • Lei Gu,
  • David Chi,
  • Jaime Reyes,
  • Jennifer Cook,
  • Elgene Lim,
  • Charles Y. Lin,
  • Wouter de Laat,
  • Prakash K. Rao,
  • Henry W. Long,
  • Myles Brown

DOI
https://doi.org/10.1016/j.celrep.2017.02.025
Journal volume & issue
Vol. 18, no. 10
pp. 2359 – 2372

Abstract

Read online

While the multiple endocrine neoplasia type 1 (MEN1) gene functions as a tumor suppressor in a variety of cancer types, we explored its oncogenic role in breast tumorigenesis. The MEN1 gene product menin is involved in H3K4 trimethylation and co-activates transcription. We integrated ChIP-seq and RNA-seq data to identify menin target genes. Our analysis revealed that menin-dependent target gene promoters display looping to distal enhancers that are bound by menin, FOXA1 and GATA3. In this fashion, MEN1 co-regulates a proliferative breast cancer-specific gene expression program in ER+ cells. In primary mammary cells, MEN1 exerts an anti-proliferative function by regulating a distinct expression signature. Our findings clarify the cell-type-specific functions of MEN1 and inform the development of menin-directed treatments for breast cancer.

Keywords